OPN-9840, a non-covalent potent pan-TEAD inhibitor, exhibits single agent efficacy in preclinical malignant mesothelioma models
- AUTHORS Chen, et al
- Programs OPN-TEAD
2024
OPN-6602, a potent dual EP300/CBP bromodomain inhibitor, targets multiple myeloma through concomitant suppression of IRF4 and c-MYC
- AUTHORS Matusow, et al
- Programs OPN-6602